AI assistant
TALPHERA, INC. — Director's Dealing 2022
Mar 4, 2022
35181_dirs_2022-03-04_72684eb4-8490-4b3c-a2ca-1640ffb5a929.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2022-03-03
Reporting Person: ASADORIAN RAFFI (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-03 | Common Stock | F | 7923 | $0.4068 | Disposed | 364205 | Direct |
Footnotes
F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
F2: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F3: Balance includes non-reportable acquisition of 4,040 shares of Common Stock through the Company's Employee Stock Purchase Plan.
F4: On February 14, 2022, the reporting person filed a Form 4 which inadvertently under-reported his holdings in the Issuer by 8 shares. In addition to reporting the current transactions, this Form 4 serves to correct the reporting person's holdings in the Issuer.